Sound Pharmaceuticals
Eric Lynch has been in the professional world since 1997, when they began their role as a Research Assistant Professor at the University of Washington, Division of Medical Genetics. In 2017, they became the President of CoSensei Inc. and, prior to that, they were a VP at Sound Pharmaceuticals, Inc.
Eric Lynch obtained their BS in Genetics from the University of California, Davis in 1988. Eric then went on to pursue a PhD in Genetics from the University of California, Berkeley, which they completed in 1995.
This person is not in any teams
Sound Pharmaceuticals
Sound Pharmaceuticals develops prescription drugs to prevent and treat sensorineural hearing loss.